Ligand Pharmaceuticals stock hits 52-week high at $169.72
PositiveFinancial Markets

Ligand Pharmaceuticals has reached a significant milestone as its stock hits a 52-week high of $169.72. This achievement reflects the company's strong performance and investor confidence, highlighting its potential for growth in the competitive pharmaceutical market. Such a high stock price can attract more investors and may lead to increased funding for future projects, which is crucial for innovation in healthcare.
— Curated by the World Pulse Now AI Editorial System